Analysts at HC Wainwright cut their FY2027 earnings per share (EPS) estimates for shares of Pharming Group in a research note ...

Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming’s management will ...

Pharming Group (PHGUF) has released an update. Pharming Group has reported a strong third quarter in 2024, with total revenues rising by 12% to $74.8 million, driven by growth in its RUCONEST ...

Encore Healthcare is committed to providing high quality products at an affordable price, says Viren Merchant, founder and ...

Providing a diverse range of perspectives from bullish to bearish, 4 analysts have published ratings on Pharming (NASDAQ:PHAR) in the last three months. The following table provides a quick ...

Oppenheimer analyst Jeff Jones lowered the firm’s price target on Pharming (PHAR) to $30 from $31 and keeps an Outperform rating on the shares following quarterly results and business update.

Pharming Group NV is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The firm offers RUCONEST ...

Why Merck Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session Avi Kapoor PayPal Posts Upbeat Earnings, Joins Sprouts Farmers Market, Stanley Black & Decker ...

RBC Capital lowered the firm’s price target on Pharming (PHAR) to EUR 1.60 from EUR 1.65 and keeps an Outperform rating on the shares.